Document is current
Any future updates will be listed below
-
Authors
Chatterjee, Ranee
Kwee, Lydia Coulter
Pagidipati, Neha
Koweek, Lynne H.
Mettu, Priyatham S.
Haddad, Francois
Maron, David J.
Rodriguez, Fatima
Mega, Jessica L.
Hernandez, Adrian
Mahaffey, Kenneth
Palaniappan, Latha
Shah, Svati H.
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03154346 at ClinicalTrials.govDocuments that mention this clinical trial
Accelerated Epigenetic Aging Is Associated With Multiple Cardiometabolic, Hematologic, and Renal Abnormalities: A Project Baseline Health Substudy
https://doi.org/10.1161/circgen.122.003772
Biological and clinical correlates of the patient health questionnaire-9: exploratory cross-sectional analyses of the baseline health study
https://doi.org/10.1136/bmjopen-2021-054741
Multi-dimensional characterization of prediabetes in the Project Baseline Health Study
https://doi.org/10.1186/s12933-022-01565-x
Abnormal Exercise Electrocardiography With Normal Stress Echocardiography Is Associated With Subclinical Coronary Atherosclerosis
https://doi.org/10.1161/circimaging.124.017380
-
Funding
Funding for this research was provided by:
Verily Life Sciences
- License Information
-
More Information
Article History
Received: 4 April 2022
Accepted: 15 June 2022
First Online: 18 July 2022
Declarations
:
: The Institutional Review Board (IRB) at each clinical site approved the protocol, and all participants provided written informed consent.
: Not applicable.
: All authors acknowledge institutional research grants from Verily Life Sciences. FH received an institutional research grant from Actelion Ltd. within the last 2 years and an institutional research grant from Precordior Ltd. KM reports grants from Verily, Afferent, the American Heart Association (AHA), Cardiva Medical Inc, Gilead, Luitpold, Medtronic, Merck, Eidos, Ferring, Apple Inc, Sanifit, and St. Jude; grants and personal fees from Amgen, AstraZeneca, Bayer, CSL Behring, Johnson & Johnson, Novartis, and Sanofi; and personal fees from Anthos, Applied Therapeutics, Elsevier, Inova, Intermountain Health, Medscape, Mount Sinai, Mundi Pharma, Myokardia, Novo Nordisk, Otsuka, Portola, SmartMedics, and Theravance outside the submitted work. AH reports grants from Verily; grants and personal fees from AstraZeneca, Amgen, Bayer, Merck, and Novartis; and personal fees from Boston Scientific outside the submitted work. FR reports equity from HealthPals and Carta, and advisory board and consulting fees from NovoNordisk, HealthPals, and Novartis. The other authors have no conflicts of interest to disclose.
